Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate-gated chloride channels are pentameric ligand-gated ion channels present in protostome invertebrates such as nematodes, arthropods, mollusks, and some parasitic species. They belong to the Cys-loop receptor superfamily and function as inhibitory channels; when activated by glutamate, they permit chloride ions to flow into cells, producing hyperpolarization, which dampens neuronal excitability. These channels are crucial for locomotor and sensory functions and are the molecular targets of widely used antiparasitic and pesticidal drugs in the macrocyclic lactone family, including ivermectin, abamectin, doramectin, eprinomectin, selamectin, moxidectin, and emamectin. Drug binding to GluCl induces sustained activation, leading to parasite paralysis and death. Emergence of resistance due to mutations in GluCl subunits is a significant challenge in clinical and agricultural applications. The specificity of GluCl for invertebrates underlies its value as a selective antiparasitic target, with minimal risk for direct effects in vertebrates.
Agonist/irreversible activator: Drugs such as ivermectin and abamectin bind and activate GluCl irreversibly, causing sustained chloride influx and neuronal/muscle hyperpolarization (paralysis and death of parasite) Potentiation of endogenous glutamate-induced channel opening (increasing channel permeability and effect)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate-gated chloride channel (parasitic) (GluCl).